Inhibitory Effects of 12-O-Tetradecanoylphorbol-13-acetate Alone or in Combination with All-trans Retinoic Acid on the Growth of Cultured Human Pancreas Cancer Cells and Pancreas Tumor Xenografts in Immunodeficient Mice
Authors:
- Xi ZhengXZXi Zheng
- Xiao Xing CuiXCXiao Xing Cui
- Amanda D. RyanARAmanda D. Ryan
- Annette HanssonAHAnnette Hansson
- Junghan SuhJSJunghan Suh
- Arnold B. RabsonARArnold B. Rabson
- Richard L. ChangRCRichard L. Chang
- Weichung Joe ShihWSWeichung Joe Shih
- Yong LinYLYong Lin
- Pamela CrowellPCPamela Crowell
- Yao Ping LuYLYao Ping Lu
- 1 October 2005
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 315 (1) , 170-187
Abstract
Treatment of cultured PANC-1, MIA PaCa-2, and BxPC-3 human pancreatic adenocarcinoma cells with 0.1 to 1.6 nM 12-O-tetradecanoylphorbol-13-acetate (TPA) for 96 h inhibited the proliferation of these cells in a dose-dependent manner, and PANC-1 and MIA PaCa-2 cells were more sensitive to TPA than BxPC-3 cells. Inhibition of proliferation by TPA in PANC-1 cells was associated with an increase in the level of p21, but this was not observed in MIA PaCa-2 or BxPC-3 cells. The TPA-induced increase of p21 in PANC-1 cells was blocked by bisindolylmaleimide or rottlerin (inhibitors of protein kinase C). Studies in NCr-immunodeficient mice with well established PANC-1 tumor xenografts indicated that daily i.p. injections of TPA strongly inhibited tumor growth, increased the percentage of caspase-3-positive cells, and decreased the ratio of mitotic cells to caspase-3-positive cells in the tumors. Studies with BxPC-3 tumors in NCr mice receiving daily i.p. injections of vehicle, TPA, all-trans retinoic acid (ATRA), or a TPA/ATRA combination showed that TPA had an inhibitory effect on tumor growth, but treatment of the animals with the TPA/ATRA combination had a greater inhibitory effect on tumor growth than TPA alone. Treatment with the TPA/ATRA combination resulted in a substantially decreased ratio of the percentage of mitotic cells to the percentage of caspase-3-positive cells in the tumors compared with tumors from the vehicle-treated control animals. The inhibitory effects of TPA on tumor growth occurred at clinically achievable blood levels.Keywords
This publication has 34 references indexed in Scilit:
- Nuclear factor‐κB and IκB kinase are constitutively active in human pancreatic cells, and their down‐regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosisCancer, 2004
- Inhibitory Effect of 12- O -Tetradecanoylphorbol-13-acetate Alone or in Combination with All- trans -Retinoic Acid on the Growth of LNCaP Prostate Tumors in Immunodeficient MiceCancer Research, 2004
- Mitogenic and antiapoptotic role of constitutive NF‐κB/Rel activity in pancreatic cancerInternational Journal of Cancer, 2003
- Enhancement of anchorage‐independent growth of human pancreatic carcinoma MIA PaCa‐2 cells by signaling from protein kinase C to mitogen‐activated protein kinaseMolecular Carcinogenesis, 2002
- Inhibition of protein kinase C μ by various inhibitors. Inhibition from protein kinase c isoenzymesFEBS Letters, 1996
- Rottlerin, a Novel Protein Kinase InhibitorBiochemical and Biophysical Research Communications, 1994
- Growth inhibition of human melanoma‐derived cells by 12‐O‐tetradecanoyl phorbol 13‐acetateInternational Journal of Cancer, 1994
- Effects of differentiation‐inducing agents on maturation of human MCF‐7 breast cancer cellsJournal of Cellular Physiology, 1990
- Differentiation capacity of human non‐small‐cell lung cancer cell lines after exposure to phorbol esterInternational Journal of Cancer, 1990
- Phorbol diester-induced macrophage differentiation of leukemic blasts from patients with human myelogenous leukemia.Journal of Clinical Investigation, 1980